Literature DB >> 23430765

Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice.

Hai-Mei Zhao1, Xiao-Ying Huang, Zhi-Qin Zuo, Qi-Hong Pan, Mei-Ying Ao, Feng Zhou, Hong-Ning Liu, Zhi-Yong Liu, Duan-Yong Liu.   

Abstract

AIM: To investigate the effect of probiotics on regulating T regulatory cells and reducing the severity of experimental colitis in mice.
METHODS: Forty C57/BL mice were randomly divided into four groups. Colitis was induced in the mice using 2,4,6-trinitrobenzene sulfonic acid (TNBS). After 10-d treatment with Bifico capsules (combined bifidobacterium, lactobacillus and enterococcus), body weight, colonic weight, colonic weight index, length of colon, and histological scores were evaluated. CD4+CD25+Foxp3+T cell in mesenteric lymph nodes were measured by flow cytometry, and cytokines in colonic tissue homogenates were analyzed by a cytometric bead array.
RESULTS: The colonic weight index and the colonic weight of colitis mice treated with Bifico were lower than that of TNBS-induced mice without treatment. However, colonic length and percent of body weight amplification were higher than in TNBS-induced mice without treatment. Compared with TNBS-induced mice without treatment, the level of CD4+CD25+Foxp3+T cells in mesenteric lymph nodes, the expression of interleukin (IL)-2, IL-4 and IL-10 in colonic tissues from colitis mice treated with Bifico were upregulated, and tumor necrosis factor-α and interferon-γ were downregulated.
CONCLUSION: Probiotics effectively treat experimental colitis by increasing CD4+CD25+Foxp3+T cell and regulating the balance of Th1 and Th2 cytokines in the colonic mucosa.

Entities:  

Keywords:  CD4CD25T cell; Cytokine; Probiotics; Ulcerative colitis

Mesh:

Substances:

Year:  2013        PMID: 23430765      PMCID: PMC3574601          DOI: 10.3748/wjg.v19.i5.742

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 2.  Control of intestinal inflammation by regulatory T cells.

Authors:  B Singh; S Read; C Asseman; V Malmström; C Mottet; L A Stephens; R Stepankova; H Tlaskalova; F Powrie
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

Review 3.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

4.  Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.

Authors:  Tomohisa Sujino; Takanori Kanai; Yuichi Ono; Yohei Mikami; Atsushi Hayashi; Tomomitsu Doi; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Hiromasa Takaishi; Haruhiko Ogata; Akihiko Yoshimura; Dan R Littman; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2011-06-07       Impact factor: 22.682

Review 5.  Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.

Authors:  Jochen Maul; Martin Zeitz
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

6.  PSC: Protect and serve with colitis: does it help the liver to have severe ulcerative colitis?

Authors:  Christian Rust; Stephan Brand
Journal:  Gut       Date:  2011-05-11       Impact factor: 23.059

7.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

8.  Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis.

Authors:  Jean-Pierre Segain; Diane Raingeard de la Blétière; Vincent Sauzeau; Arnaud Bourreille; Gréory Hilaret; Chrystelle Cario-Toumaniantz; Pierre Pacaud; Jean-Paul Galmiche; Gervaise Loirand
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Therapeutic effects of four strains of probiotics on experimental colitis in mice.

Authors:  Lin Lin Chen; Xue Hong Wang; Yi Cui; Guang Hui Lian; Jie Zhang; Chun Hui Ouyang; Fang Gen Lu
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

10.  Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis.

Authors:  D Berrebi; J Languepin; L Ferkdadji; A Foussat; P De Lagausie; R Paris; D Emilie; J F Mougenot; J P Cezard; J Navarro; M Peuchmaur
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-09       Impact factor: 2.839

View more
  16 in total

1.  Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.

Authors:  Li Zuo; Kai-Tao Yuan; Li Yu; Qing-Hong Meng; Peter Chee-Keung Chung; Ding-Hua Yang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines.

Authors:  Yanlin Zhou; Fan Zhang; Liqi Mao; Tongfei Feng; Kaijie Wang; Maosheng Xu; Bin Lv; Xi Wang
Journal:  Eur J Nutr       Date:  2022-08-02       Impact factor: 4.865

3.  Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice.

Authors:  Ana Letícia Malheiros Silveira; Adaliene Versiani Matos Ferreira; Marina Chaves de Oliveira; Milene Alvarenga Rachid; Larissa Fonseca da Cunha Sousa; Flaviano Dos Santos Martins; Ana Cristina Gomes-Santos; Angelica Thomaz Vieira; Mauro Martins Teixeira
Journal:  Eur J Nutr       Date:  2015-10-12       Impact factor: 5.614

4.  Genome Sequence of the Bacterium Bifidobacterium longum Strain CMCC P0001, a Probiotic Strain Used for Treating Gastrointestinal Disease.

Authors:  Hongjing Yu; Lu Liu; Zhen Chang; Shasha Wang; Bin Wen; Peijun Yin; Datao Liu; Bei Chen; Jundong Zhang
Journal:  Genome Announc       Date:  2013-09-12

5.  FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.

Authors:  Carissa M Thomas; Delphine M A Saulnier; Jennifer K Spinler; Peera Hemarajata; Chunxu Gao; Sara E Jones; Ashley Grimm; Miriam A Balderas; Matthew D Burstein; Christina Morra; Daniel Roeth; Markus Kalkum; James Versalovic
Journal:  Microbiologyopen       Date:  2016-06-28       Impact factor: 3.139

Review 6.  Recipe for IBD: can we use food to control inflammatory bowel disease?

Authors:  Mario Witkowski; Marco Witkowski; Nicola Gagliani; Samuel Huber
Journal:  Semin Immunopathol       Date:  2017-11-09       Impact factor: 9.623

7.  Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling.

Authors:  Huan Song; Weiyi Wang; Bo Shen; Hao Jia; Zhaoyuan Hou; Ping Chen; Yunwei Sun
Journal:  Cancer Sci       Date:  2018-02-14       Impact factor: 6.716

Review 8.  Immobilization technologies in probiotic food production.

Authors:  Gregoria Mitropoulou; Viktor Nedovic; Arun Goyal; Yiannis Kourkoutas
Journal:  J Nutr Metab       Date:  2013-10-28

Review 9.  Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's Disease.

Authors:  Kuan Wang; Lu-Yi Wu; Chuan-Zi Dou; Xin Guan; Huan-Gan Wu; Hui-Rong Liu
Journal:  Gastroenterol Res Pract       Date:  2016-08-29       Impact factor: 2.260

10.  Quantitative Analysis of Intestinal Flora of Uygur and Han Ethnic Chinese Patients with Ulcerative Colitis.

Authors:  Ping Yao; Min Cui; Haikun Wang; Hongliang Gao; Lei Wang; Tao Yang; Yongbo Cheng
Journal:  Gastroenterol Res Pract       Date:  2015-12-29       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.